IPP Bureau
FDA expands nod of Eli Lilly’s Jaypirca for earlier CLL/SLL treatment
By IPP Bureau - December 04, 2025
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
Roche launches first rapid point-of-care test for whooping cough
By IPP Bureau - December 04, 2025
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
BPL Medical Technologies unveils critical-care innovations at ISACON 2025
By IPP Bureau - December 04, 2025
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
FDA nod to priority review to AstraZeneca’s Baxdrostat for hard-to-control hypertension
By IPP Bureau - December 04, 2025
Here's a development that aims to keep your blood pressure in check. Literally!
Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
By IPP Bureau - December 04, 2025
The company is excluding data from the affected sites to maintain the study's integrity
Promotion of indigenous pharmaceutical manufacturing
By IPP Bureau - December 04, 2025
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Zydus receives EIR for the injectable facility located at Jarod
By IPP Bureau - December 04, 2025
This inspection was conducted following the warning letter issued by the USFDA
Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
By IPP Bureau - December 03, 2025
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Imugene reports strong early results for Azer-cel in aggressive blood cancer trial
By IPP Bureau - December 03, 2025
Celltrion gets Health Canada nod for Eylea biosimilar Eydenzelt
By IPP Bureau - December 03, 2025
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
By IPP Bureau - December 03, 2025
Angelini Ventures has already invested €125 million in 22 startups
L&T Technology unveils next-gen AI digital twin for lung diagnostics
By IPP Bureau - December 03, 2025
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Citius Oncology's new therapy offers new hope for cutaneous T-cell lymphoma patients
By IPP Bureau - December 03, 2025
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
Merck unveils first human data for Alzheimer’s candidates
By IPP Bureau - December 03, 2025
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
Sound's for hearing loss: Co's drug wins FDA breakthrough tag for Meniere’s disease
By IPP Bureau - December 03, 2025
Here's a new ray of hope for new hope for patients suffering from Meniere’s disease (MD) and sensorineural hearing loss
